Accendra Health (ACH) Cash from Investing Activities (2009 - 2026)

Accendra Health (ACH) has reported Cash from Investing Activities for 18 consecutive years, with $53.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 211.88% year-over-year to $53.9 million; the TTM figure through Mar 2026 stood at $246.5 million (up 251.38% YoY), while the FY2025 annual figure was $144.4 million, up 223.93% from the prior year.
• Cash from Investing Activities slipped to $53.9 million in Q1 2026 per ACH's latest filing, from $285.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $285.0 million in Q4 2025 and bottomed at -$1.6 billion in Q1 2022.
• Historically, Cash from Investing Activities has averaged -$109.4 million across 5 years, with a median of -$34.2 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 23880.0% — and 2025, when it jumped 644.9%.
• Accendra Health's Cash from Investing Activities stood at -$32.8 million in 2022, then fell by 18.75% to -$38.9 million in 2023, then sank by 34.41% to -$52.3 million in 2024, then surged by 644.9% to $285.0 million in 2025, then slumped by 81.08% to $53.9 million in 2026.
• Business Quant data shows ACH's Cash from Investing Activities at $53.9 million in Q1 2026, $285.0 million in Q4 2025, and -$39.5 million in Q3 2025.